Stock Rich List
#541 on the corporate holders of 809 holders

Mpm Oncology Innovations Fund LP

10% owner at Aktis Oncology; 10% owner at Werewolf Therapeutics.

$149M
in disclosed stock, +$2.5M (+1.74%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
541st of 809
Companies held
2
Largest holding
AKTS, 98.0% of total
Latest SEC filing
Jan 12, 2026
Listed but not counted
$27.2M

What the $149M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Aktis Oncology AKTS
Common Stock
Indirectly (see filing footnote)
Reported jointly by 2 insiders; split evenly
5,130,032$16.40$84.1M56.4%Form 4, Jan 12, 2026
Aktis Oncology AKTS
Common Stock
Indirectly (see filing footnote)
Reported jointly by 2 insiders; split evenly
3,785,084$16.40$62.1M41.6%Form 4, Jan 12, 2026
Werewolf Therapeutics HOWL
Common Stock
Through AM LLC
Reported jointly by 2 insiders; split evenly
2,952,360$0.99$2.9M2.0%Form 4, Nov 6, 2025

Share counts are the amounts Mpm Oncology Innovations Fund LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Mpm Oncology Innovations Fund LP's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Aktis Oncology AKTS
Common Stock
Through MPM Asset Management LLC
Held by an investment fund or partnership
1,655,971$16.40$27.2M—Form 4, Jan 12, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jan 12, 2026BoughtAKTS1,112,777$18.00$20.0MView
Nov 6, 2025SoldHOWL54,452$1.21$66KView
Nov 5, 2025SoldHOWL47,950$1.22$58KView
Nov 4, 2025SoldHOWL140,488$1.22$171KView
Nov 3, 2025SoldHOWL94,063$1.29$121KView
Oct 31, 2025SoldHOWL114,044$1.28$146KView
Oct 30, 2025SoldHOWL86,936$1.43$124KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
538Siddhi Sponsor LLC
10% owner, Siddhi Acquisition
$150M+$141K (+0.09%)
539Sequoia Capital Usv Xiv Holdco, Ltd.
10% owner, DoorDash
$150M−$9.2M (−5.80%)
540SCGGF III - U.S./India Management, L.P.
10% owner, DoorDash
$150M−$9.2M (−5.80%)
541Mpm Oncology Innovations Fund LP
10% owner, Aktis Oncology
$149M+$2.5M (+1.74%)
542Public Sector Pension Investment Board
10% owner, D-Wave Quantum
$149M−$7.7M (−4.94%)
543SC U.S. Growth VII Management, L.P.
10% owner, Airbnb
$149M−$8.0M (−5.09%)
544Smiths Group International Holdings Ltd
Insider, ICU Medical
$147M−$2.3M (−1.52%)

Other Aktis Oncology insiders

All AKTS insiders

Questions

How much stock does Mpm Oncology Innovations Fund LP own?

Mpm Oncology Innovations Fund LP holds $149,118,929 in listed stock based on SEC filings and current prices, mostly Aktis Oncology (AKTS). That ranks 541st on the Stock Rich List.

Is this Mpm Oncology Innovations Fund LP's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Mpm Oncology Innovations Fund LP last buy or sell stock?

The most recent open-market trade on file is a purchase of 1,112,777 AKTS shares on Jan 12, 2026 at $18.00.

Files jointly with Ansbert Gadicke, SEC filer 1134657.